Difference between revisions of "Part:BBa K1462520:Design"
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K1462520 short</partinfo> | <partinfo>BBa_K1462520 short</partinfo> | ||
Line 7: | Line 6: | ||
===Design Notes=== | ===Design Notes=== | ||
− | + | This device is composed of three parts "GAL1 + BFP + GBD ligand + ADH1"<bbpart>BBa_K1462490<bbpart/>,"GAL1 + GFP + BFP ligand + ADH1"<bbpart>BBa_K1462500<bbpart/> and <bbpart>BBa_K1462510<bbpart/>. We planned to transmit this device to yeast with the different scale group of GBD,PDZ and SH3 scaffold protein. | |
− | + | ||
===Source=== | ===Source=== | ||
+ | This device is composed of three parts "GAL1 + BFP + GBD ligand + ADH1"<bbpart>BBa_K1462490<bbpart/>,"GAL1 + GFP + BFP ligand + ADH1"<bbpart>BBa_K1462500<bbpart/> and <bbpart>BBa_K1462510<bbpart/>. | ||
− | + | ===References=== | |
− | + | [1] John E Dueber, Gabriel C Wu, G Reza Malmirchegini, et al.Synthetic protein scaffolds provide modular control | |
+ | over metabolic flux.Nat Biotechnol. 2009 Aug;27(8):753-9. <br/> | ||
+ | [2] Schultz, J. et al. Specific interactions between the syntrophin PDZ domain and | ||
+ | voltage-gated sodium channels. Nat Struct Biol 5, 19-24 (1998).<br/> | ||
+ | [3] Kim, A.S., Kakalis, L.T., Abdul-Manan, N., Liu, G.A. & Rosen, M.K. | ||
+ | Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome | ||
+ | protein. Nature 404, 151-158 (2000).<br/> | ||
+ | [4] Wu, X. et al. Structural basis for the specific interaction of lysine-containing | ||
+ | proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215-226 (1995).<br/> | ||
+ | [5] Harris, B.Z., Hillier, B.J. & Lim, W.A. Energetic determinants of internal motif | ||
+ | recognition by PDZ domains. Biochemistry 40, 5921-5930 (2001).<br/> | ||
+ | [6] Dueber, J.E., Yeh, B.J., Chak, K. & Lim, W.A. Reprogramming control of an | ||
+ | allosteric signaling switch through modular recombination. Science 301, 1904-1908 (2003).<br/> | ||
+ | [7] Nguyen, J.T., Turck, C.W., Cohen, F.E., Zuckermann, R.N. & Lim, W.A. | ||
+ | Exploiting the basis of proline recognition by SH3 and WW domains: design of | ||
+ | N-substituted inhibitors. Science 282, 2088-2092 (1998).<br/> |
Revision as of 18:00, 14 October 2014
GAL1+YFP+SH3-lig+ADH1+GAL1+GFP+PDZ-lig+ADH1+GAL1+BFP+GBD-lig+ADH1
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 150
Illegal AgeI site found at 1755
Illegal AgeI site found at 3300 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 2804
Design Notes
This device is composed of three parts "GAL1 + BFP + GBD ligand + ADH1"BBa_K1462490